Skip to content
2000
Volume 3, Issue 1
  • ISSN: 2211-5552
  • E-ISSN: 2211-5544

Abstract

Purpose: To investigate the association between changes on [18F] fluorodeoxyglucose positron emission tomography (FDG-PET) and clinical deterioration in patients with moderate Alzheimer’s disease (AD), findings of FDG-PET in the first and follow-up stages were compared using stereotactic extraction estimation (SEE) and three-dimensional stereotactic surface projection (3D-SSP). Methods and patients: Thirty consecutive patients with AD examined twice by FDG-PET were divided into two groups with improved or stable mini-mental state examination (MMSE) (SI group, 14 patients) and deteriorated MMSE (D group, 16 patients). Statistical analysis using SEE in 3D-SSP was used to investigate the changes in Z-score in the frontal, parietal, temporal, and occipital lobes, precuneus, and posterior cingulate cortex (PCC). Results: Changes in Z-scores in the PCC (p=0.0006) and temporal lobe (p=0.021) were significantly higher in the D group than in the SI group. Z-score was significantly higher in the left PCC compared to the right PCC (p=0.0097). Conclusions: SEE in 3D-SSP is the helpful method to detect the regional differences. Metabolic reduction on FDG-PET in the left PCC detected by SEE and 3D-SSP is associated with clinical deterioration in patients with moderate AD.

Loading

Article metrics loading...

/content/journals/cmi/10.2174/2211555203666140423225138
2014-03-01
2025-09-02
Loading full text...

Full text loading...

/content/journals/cmi/10.2174/2211555203666140423225138
Loading

  • Article Type:
    Research Article
Keyword(s): 3D-SSP; Alzheimer's disease; FDG-PET; Stereotactic extraction estimation
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test